Form 13-F position report

MDXHEALTH SA

Reported by Bleichroeder LP

MDXH CUSIP B5950S113 Manager CIK 0001781002

Reported 31,034,442 shares, up 23,656,109 (320.6%) from the prior quarter.

Reported value 498.9%; share count 320.6% vs. the prior quarter.

Added
% of reported 13F value 1.79% This manager · Q3 2026
Shares 31,034,442 Quarter-end amount reported
Reported value $18,142,735 Fair value at quarter end
Consecutive quarters held 12 Through Q3 2026

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2023-12-31 15025765
2024-03-31 10044882
2024-06-30 9269216
2024-09-30 17426933
2024-12-31 17486649
2025-03-31 10477233
2025-06-30 16306116
2025-09-30 34309248
2025-12-31 26340649
2026-03-31 16970166
2026-06-30 3029544
2026-09-30 18142735

Quarterly position history

How this manager's reported quarter-end position changed over time.

12 quarters
Quarterly reported position history for MDXHEALTH SA held by Bleichroeder LP.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q3 2026 Added 31,034,442 +23,656,109 (320.6%) 1.79% $18,142,735 2026-11-13
Q2 2026 Unchanged 7,378,333 0 (0.0%) 0.54% $3,029,544 2026-08-13
Q1 2026 Unchanged 7,378,333 0 (0.0%) 2.93% $16,970,166 2026-05-14
Q4 2025 Unchanged 7,378,333 0 (0.0%) 4.63% $26,340,649 2026-02-13
Q3 2025 Unchanged 7,378,333 0 (0.0%) 6.69% $34,309,248 2025-11-14
Q2 2025 Unchanged 7,378,333 0 (0.0%) 4.01% $16,306,116 2025-08-14
Q1 2025 Unchanged 7,378,333 0 (0.0%) 2.79% $10,477,233 2025-05-15
Q4 2024 Reduced 7,378,333 -1,000,000 (-11.9%) 4.39% $17,486,649 2025-02-14
Q3 2024 Added 8,378,333 +4,500,000 (116.0%) 4.69% $17,426,933 2024-11-13
Q2 2024 Unchanged 3,878,333 0 (0.0%) 2.76% $9,269,216 2024-08-13
Q1 2024 Unchanged 3,878,333 0 (0.0%) 2.51% $10,044,882 2024-05-14
Q4 2023 New 3,878,333 +3,878,333 (0.0%) 3.34% $15,025,765 2024-02-12

Who else reported the position

29 managers reported MDXHEALTH SA for Q3 2026.

Managers reporting MDXHEALTH SA in Q3 2026.
Manager Activity Shares Change % of reported 13F Reported value Tenure
Bleichroeder LP This report Added 31,034,442 +23,656,109 1.79% $18,142,735 12 qtrs
MVM Partners LLC Added 6,652,400 +1,951,943 100.0% $3,852,405 12 qtrs
AWM Investment Company Inc New 3,956,626 +3,956,626 0.22% $2,313,044 9 qtrs
PERKINS CAPITAL MANAGEMENT INC Reduced 1,286,920 -124,971 0.54% $752,333 12 qtrs
GSA CAPITAL PARTNERS LLP Added 593,350 +111,365 0.02% $347,000 5 qtrs
JANE STREET GROUP LLC Reduced 299,295 -203,924 < 0.01% $174,968 5 qtrs
CITADEL ADVISORS LLC Reduced 262,526 -247,148 < 0.01% $153,473 9 qtrs
RENAISSANCE TECHNOLOGIES LLC Reduced 224,982 -100,102 < 0.01% $131,524 9 qtrs
BlackRock Inc Reduced 143,015 -4,048 < 0.01% $83,606 6 qtrs
MILLENNIUM MANAGEMENT LLC Reduced 119,972 -108,538 < 0.01% $70,136 5 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
September 30, 2026
Filed
November 13, 2026
Filing type
13F-HR
Position type
SHS NEW

Voting authority reported

Sole
31,034,442
Shared
0
None
0

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.